Previous studies on primary T-ALL patient samples indicated that CD7+CD1a− population is enriched for L-IC activity, suggesting that T-lineage-committed DN3-like progenitors harbor L-ICs in T-ALL patients, mirroring findings in mouse models [6]. The gene discussed is CD7; the disease is acute lymphoblastic leukemia.